Please login to the form below

Not currently logged in

PharmaLex strengthens international team

Consultancy group appoints Adrian Pencak

Adrian PencakPharmaLex Group has appointed new executive vice president, business development and marketing in the form of Adrian Pencak.

Pencak joins the German consultancy group following over 25 years’ global business development, marketing and operations experience, spanning the life sciences and healthcare sectors.

He said: “I am very excited to have joined the PharmaLex management team as we are a company with ambitious growth targets as well as extremely high standards of services.

“I’m looking forward to playing a key role in our continued growth and success, with a special focus on the US.”

He joins the group from ICON, where he was vice president, global business development early phase services.

Dr Thomas Dobmeyer, chief executive officer at PharmaLex, said: “Adrian’s appointment demonstrates our commitment to developing our global infrastructure and sales.

“Alongside his strong business development experience, Adrian’s background in the IT space will also support our artificial intelligence and innovative led services.”

24th October 2017

From: Sales



Featured jobs

Subscribe to our email news alerts


Add my company

emotive. is an award-winning healthcare communications agency working with leading global and EMEA companies in life sciences including medical device...

Latest intelligence

The Biosimilar Challenge
How health behaviours and clinical outcomes are related
When HCPs understand patient activation levels they can actively guide patients towards more confident self-management of diverse health concerns....
The Periodic Table of Healthcare Communications
The definitive framework for building healthcare communication strategies and plans. Covering Brand Planning, Customer Experience and Multi-channel Marketing....